Leadership Team

An experienced team in the field of medical devices, business and regulatory affairs, specifically in cardiology and cardiac support.

Louis de Lillers,
CEO

Louis brings extensive experience in finance and developing or commercializing new technologies. Since taking on the role of CEO in 2015, he has transformed CorWave from a small R&D startup into a full fledge medical device scaleup. Being a self-trained computer programmer, Louis founded several ventures in the early 2000s and consequently joined Ernst&Young, where he embarked on missions with SMEs and high-growth companies. He subsequently became analyst at Clipperton Finance, a corporate finance boutique, focusing on mergers & acquisitions and venture capital transactions. He was then part of the information technology investment team at Sofinnova Partners. Prior to joining CorWave, he was co-founder and CEO of PlugMed, a medtech company developing innovative devices for LVADs and hemodialysis. Louis graduated from EDHEC Business School with a Master in Management and holds a university degree in artificial heart and circulatory support from Pitié-Salpêtrière. Louis is a board member of France Biotech, an association representing the healthcare innovation sector in France, and Start Industrie, an organization dedicated to supporting French industrial startups and scaleups.

Andreas Fleischli,
CTO

Andreas brings about 30 years of expertise in the development of Left Ventricular Assist Devices (LVADs), spanning device innovation, engineering, industrialization, regulatory approval, and production scale-up. As an internationally recognized authority in magnetically levitated pump technologies, he played a key role in pioneering and manufacturing at scale the most implanted LVAD worldwide to date, a product that has generated over $4 billion in cumulative revenues. Over the course of his career, he has held senior engineering and leadership roles at leading medical device companies, including Thoratec. In his different roles, he drove innovation in next-generation Mechanical Circulatory Support technologies and led major R&D and manufacturing programs. Andreas holds an MS in Electrical Engineering and Information Technology from ETH Zurich.

 

Dawn Sadlowski-Buisserez,
Vice President, Operations

Dawn brings to CorWave 30 years of industrial experience, including 15 years focused on the manufacturing of active implantable medical devices — a key asset to support CorWave’s industrial growth and clinical transition. Before joining CorWave, Dawn led the LivaNova/MicroPort CRM manufacturing site in Clamart France, one of Europe’s largest clean rooms for active implantable medical devices, producing tens of thousands of life-saving devices annually.  A graduate of Rutgers University’s College of engineering with an MBA from Sciences Po, Dawn began her career at Alcatel (today Nokia) in the U.S. before managing optical fiber production and expansion activities in France.  She later joined Lear Corporation, a global leader in automotive interiors, where she served as a Six-Sigma continuous improvement champion across manufacturing facilities throughout western Europe. In 2009, she transitioned to Sorin CRM (later LivaNova and MicroPort) where she oversaw industrial quality for pacemakers and defibrillators manufacturing before advancing to Director of Operations of the Clamart site.  She later drove strategic initiatives, including portfolio expansion in China and MDR compliance, following the company’s acquisition by MicroPort.

Daniel Lexcen,
Vice President, Clinical & Scientific Affairs

Daniel Lexcen joins CorWave with extensive experience in heart failure clinical research and global clinical program execution. Over the past decade in the medical device industry, including leadership roles in global clinical research, he contributed to the design and execution of numerous international clinical trials across the United States, Europe, Australia, and Japan. His experience spans the full product development lifecycle, from early clinical studies to post-market programs, and in close collaboration with investigators, regulatory authorities, and key opinion leaders. Prior to joining CorWave, Daniel led the global clinical research strategy for cardiac rhythm at Medtronic. Daniel holds a PhD in Integrated Biosciences from the University of Minnesota and is the co-author of more than 45 peer-reviewed publications, including in top-tier journals (e.g., NEJM & JACC).

 

Anne Chevalier,
Vice President, Human Resources

Anne brings over 20 years of Human Resources experience, gained in diverse environments ranging from fast-growing SMEs to major pharmaceuticals companies. Before joining CorWave, Anne served as the Human Resources Director at IPSEN, a leading French biopharmaceutical company, where she was responsible for two R&D French sites with more than 450 employees. Her scope included managing highly skilled international teams. From 2016 to 2021, Anne was Senior HR Business Partner at Pfizer, supporting local teams for the transformation projects and organizational changes (medical, sales, regulatory affairs, market access) for the internal medicine, Inflammation and Immunology and rare diseases that she also supported globally. She led organizational development and transformation initiatives during a period of significant change. Earlier in her career, Anne spent eight years at Cunningham Lindsey France (formerly Gab Robins), an insurance loss-adjusting firm, where she progressed from HR Manager to Deputy HR Director. In this role, she played a key role in supporting the company’s rapid growth from 250 employees to 1,000 employees over the period. She began her career as a recruitment consultant at Manpower, gaining valuable experience in talent acquisition and management. Anne holds a degree in Social Law from the University of Nottingham (UK) and a Master’s in Human Resources from ESSEC, a leading French business school.